Result of Broker Option
This announcement contains inside information for the purposes of Regulation 11 of the Market Abuse (Amendment) (EU Exit) Regulations 2019/310. With the publication of this announcement via a Regulatory Information Service, this inside information is now considered to be in the public domain.
6 May 2021
Location Sciences Group PLC
("Location Sciences" or the "Company")
Result of Broker Option
The Company is pleased to announce that the Broker Option was significantly oversubscribed by both existing Shareholders and non-Shareholders. However, Turner Pope in consultation with the Company decided that it would be in the interests of the Company's Shareholders as a whole if the Broker Option was only partially exercised, taking into account inter alia the existing shareholdings of validated Shareholders who applied. As a result, the Company has been notified by Turner Pope that it intends to exercise its Broker Option in respect of 87,500,000 new Ordinary Shares.
As announced on 4 May 2021, the Company conditionally raised a total of £3.5 million (before expenses) via a conditional Placing and a conditional Subscription. In tandem with this, Location Sciences granted the Broker Option, which has now closed, to Turner Pope to provide the opportunity for existing Shareholders to participate in the fundraise undertaken by the Company. The details of the Placing, Subscription and Broker Option were provided in the Company's announcement of 4 May 2021 and the terms defined in that announcement have been used in this release.
Turner Pope, the Company's Placing Agent, has determined all Broker Option Share allocations at its discretion (after consultation with the Company) and has notified counterparties of the number of Broker Option Shares they have been allocated.
As previously disclosed, the Placing and the Subscription are conditional, amongst other things, upon the approval of Shareholders at a General Meeting of the Company. The Broker Option, comprising 175,000,000 new Ordinary Shares in the Company, is also conditional upon the approval of shareholders at the General Meeting.
The Broker Option has conditionally raised £175,000 (before expense) at a price of 0.2 pence per share through the issue of 87,500,000 new Ordinary Shares.
Admission of Placing and Broker Option Shares
Application will be made for the Broker Option Shares together with the Placing Shares, the Subscription Shares and the Fees Shares (excluding 42,500,000 Fees Shares in respect of the second year's fees of the Proposed Directors) to be admitted to trading on AIM following the approval of the Resolutions. Admission is expected to become effective by no later than 8.00 a.m. on 25 May 2021. Settlement of the Placing Shares, the Subscription Shares, the Broker Option Shares and the Fees Shares (excluding 42,500,000 Fees Shares in respect of the second year's fees of the Proposed Directors) is expected to take place within the CREST system in conjunction with Admission.
A copy of this announcement is available on the Company's website https://www.locationsciencesgroup.ai/investor-relations/rns-news-alerts/ .
For further information please contact:
Location Sciences Group PLC via Milk & Honey PR
Mark Slade, Chief Executive Officer
David Rae, CFO and Commercial Director
Allenby Capital Limited (Nominated Adviser) Tel: +44 (0)20 3328 5656
David Hart
David Worlidge
Turner Pope Investments (TPI) Ltd (Placing Agent) Tel: +44 (0)20 3657 0050
James Pope
Andy Thacker
Peterhouse Capital (Broker) Tel: +44 (0) 20 7220 9791
Charles Goodfellow
Eran Zucker
Milk & Honey PR Tel: +44 (0)20 3637 7310
Kirsty Leighton
Jessica Ballinger
About Location Sciences Group PLC:
Location Sciences is the pre-eminent global location verification provider to the $160 billion digital advertising industry. Working in partnership with brands, media agencies and suppliers to reduce ad-wastage and improve the effectiveness of location-based advertising campaigns.
The digital advertising market-place remains unregulated and un-monitored, with an estimated $19 billion wasted on ad-fraud in 2018. Location Sciences has developed Verify, the world's first independent location verification product. Utilising sophisticated machine learning and pattern recognition technologies, Verify detects location ad-fraud and shines a light on location data inaccuracy with the aim of bringing back integrity, transparency and trust to the market place.
Rule 26 website: www.locationsciencesgroup.ai
Verify website: www.locationsciences.ai
LinkedIn: https://www.linkedin.com/company/locationsciences
Twitter: @LocationSci
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Latest directors dealings
- 2 days ago City of London Investment Group
- 2 days ago Aberdeen Group plc
- 2 days ago NATWEST GROUP
- 2 days ago Ondo Insurtech
- 2 days ago Banco Santander S.A.